Emergency Department Management for PRES
Immediately control blood pressure with parenteral antihypertensives while simultaneously managing seizures with benzodiazepines, followed by levetiracetam as the preferred second-line agent, and obtain urgent brain MRI to confirm the diagnosis. 1, 2
Initial Stabilization and Blood Pressure Control
The cornerstone of PRES management is gradual blood pressure reduction to avoid sudden hypoperfusion of vital organs 3, 4. Use intravenous nicardipine or other parenteral antihypertensives for controlled BP lowering 1. The goal is not precipitous normalization but rather a measured 15-25% reduction in mean arterial pressure over the first hour. Aggressive, rapid BP reduction can paradoxically worsen cerebral perfusion and outcomes.
Critical Pitfall to Avoid
Do not lower blood pressure too rapidly—this can cause cerebral hypoperfusion and worsen neurological outcomes despite treating the underlying hypertensive crisis 3.
Seizure Management
If seizures are present:
- First-line: Administer appropriately dosed benzodiazepines immediately 5, 1
- Second-line: If seizures persist despite benzodiazepines, use levetiracetam, fosphenytoin, or valproate with similar efficacy 5
Levetiracetam is particularly advantageous in PRES because it requires dose adjustment for renal impairment (common in PRES patients) and has a favorable safety profile with only 0.7% risk of life-threatening hypotension compared to 3.2% with fosphenytoin 5, 1. The ESETT trial demonstrated 47% seizure cessation with levetiracetam versus 45% with fosphenytoin and 46% with valproate—essentially equivalent efficacy 5.
Short-term antiseizure therapy forms part of the treatment cornerstone, even for patients who present with seizures that have already terminated 2.
Diagnostic Confirmation
Obtain brain MRI (not CT) as the definitive diagnostic modality 6, 4, 2. MRI reveals characteristic bilateral T2-weighted hyperintensities in posterior subcortical white matter regions, representing vasogenic edema 6, 4. While CT may show hypodensities suggestive of PRES, MRI is required for confirmation 1.
Key Diagnostic Considerations
- PRES can occur without hypertension—do not exclude the diagnosis based on normal blood pressure 6
- Up to 60-90% of PRES patients present with seizures, particularly younger patients 2
- Clinical presentation includes headache (including thunderclap headache), altered mental status, visual disturbances (including transient cortical blindness), and focal neurological deficits 1, 7, 8
Identify and Address Precipitating Factors
Recognize high-risk populations and triggers 7, 2:
- Chronic hypertension and hypertensive crisis
- Chronic renal disease and acute kidney injury
- Autoimmune diseases (e.g., Goodpasture's disease)
- Immunosuppressive therapy
- Sepsis
- Pre-eclampsia/eclampsia
- Cytotoxic agents
Withdraw or adjust offending medications if immunosuppressive or cytotoxic agents are implicated 2.
Disposition and Monitoring
Admit to the intensive care unit for continuous blood pressure monitoring, neurological assessment, and management of complications 1, 2. Patients require close observation for:
- Intracranial hemorrhage (potential complication)
- Cerebral infarction
- Recurrent seizures
- Development of "malignant PRES" requiring aggressive interventions 8
Prognosis and Follow-up
While most patients show clinical and radiologic recovery within weeks, mortality ranges from 10-19%, and 40-44% experience persistent neurological deficits or residual radiologic lesions 2. Early recognition and prompt ED treatment are crucial to prevent irreversible neurological damage 1, 7. The condition is not always reversible despite its name 4.
Special Populations
Pediatric, obstetric, and transplant patients require tailored evaluation due to distinct risk profiles 2. Adjust antiseizure medication dosing for renal impairment, which is common in PRES 1.